1.Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence is not a edictive factor for response to interferon-alpha therapy and development of patocellular carcinoma.
Si Hyun BAE ; Young Min PARK ; Duck Gi YOO ; Jong Young CHOI ; Byung Hun BYUN ; Jin Mo YANG ; Chang Don LEE ; Sang Bok CHA ; Doo Ho PARK ; Boo Sung KIM
Journal of Korean Medical Science 2000;15(1):53-58
		                        		
		                        			
		                        			Genetic changes between codons 2209 and 2248 of NS5A of genotype 1b hepatitis C virus (HCV-1b) have been reported to be associated with the sensitivity to interferon-alpha (IFN-alpha). The present study was performed to analyze such relationship in Korean patients with chronic hepatitis C and HCV-1b (n=19), including 12 chronic hepatitis C patients treated with IFN-alpha, 3 chronic hepatitis C patients without treatment as controls, and 4 patients with hepatocellular carcinoma (HCC). Two serum samples, before and after the treatment, were analyzed for the mutations by reverse transcription-polymerase chain reaction, cloning and sequencing. The mutations were identified in 32% (6/19), including five intermediate type (1-3 mutations) and one mutant type (4 or more). In 12 patients treated with IFN-alpha, the number of amino acid substitutions in NS5A2209-2248 was not associated with outcome of the treatment.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Amino Acid Sequence
		                        			;
		                        		
		                        			Antiviral Agents/therapeutic use*
		                        			;
		                        		
		                        			Base Sequence
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular/virology*
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular/blood
		                        			;
		                        		
		                        			Codon
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Hepatitis C, Chronic/virology*
		                        			;
		                        		
		                        			Hepatitis C, Chronic/drug therapy*
		                        			;
		                        		
		                        			Hepatitis C, Chronic/blood
		                        			;
		                        		
		                        			Hepatitis C-Like Viruses/isolation & purification
		                        			;
		                        		
		                        			Hepatitis C-Like Viruses/genetics*
		                        			;
		                        		
		                        			Hepatitis C-Like Viruses/classification
		                        			;
		                        		
		                        			Human
		                        			;
		                        		
		                        			Interferon-alpha/therapeutic use*
		                        			;
		                        		
		                        			Liver Neoplasms/virology*
		                        			;
		                        		
		                        			Liver Neoplasms/blood
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Age
		                        			;
		                        		
		                        			Molecular Sequence Data
		                        			;
		                        		
		                        			Mutation*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Reverse Transcriptase Polymerase Chain Reaction
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail